Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 9/11/2018
SIETES contiene 92577 citas

 
 
 1 a 20 de 97 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Nguyen TTH, Roussin A, Rousseau A, Montastruc J-L, Montastruc F. Role of serotonin transporter in antidepressant-induced diabetes mellitus: A pharmacoepidemiological–pharmacodynamic study in VigiBase®. Drug Saf 2018;41:noviembre. [Ref.ID 102840]
2. Cita con resumen
Gicquel C, Moulis F, Chenaf C, Gouraud A, Drici M, Bondon-Guitton E, Montastruc F, Montastruc J-L. Duloxetine and gingival bleeding: a case-report and reviews of the French and world Pharmacovigilance databases and literature. Eur J Clin Pharmacol 2017;73:1197-8. [Ref.ID 102026]
3.Tiene citas relacionadas Cita con resumen
Fournier JP, Azoulay L, Yin H, Montastruc J-L, Suissa S. Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain. JAMA Intern Med 2014;175:186-93. [Ref.ID 98791]
4.
Durrieu G, Mazau B, Jégu J, Lapeyre-Mestre M, Delord J-P, Montastruc J-L, and the French network of Regional Pharmacovigilance Centers. Drugs and cancer: an analysis of the French Pharmacovigilance Database. Therapie 2013;68:149-54. [Ref.ID 96042]
5. Cita con resumen
Montastruc J-L. Médicaments et drogues à l'origine de dysfonctions érectiles. Bulletin d'Informations de Pharmacologie 2013;20:2. [Ref.ID 95184]
6. Cita con resumen
Gulmez SE, Larrey D, Pageaux GP, Lignot S, Lassalle R, Jové J, Gatta A, McCormick PA, Metselaar HJ, Monteiro E, Thorburn D, Bernal W, Zouboulis-Vafiadis I, de Vries C, Perez-Gutthann S, Sturkenboom M, Bénichou J, Montastruc J-L, Horsmans Y, Salvo F, Hamoud F, Micon S, Droz-Perroteau C, Blin P, Moore N. Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen). The Multinational Case-Population SALT Study. Drug Saf 2013;36:135. [Ref.ID 94864]
7. Cita con resumen
Fuzier R, Serres I, Guitton E, Lapeyre-Mestre M, Montastruc J-L, The French Network of Pharmacovigilance Centres. Adverse drug reactions to gabapentin and pregabalin. A review of the French Pharmacovigilance Database. Drug Saf 2013;36:55-62. [Ref.ID 94652]
8. Cita con resumen
Fournier J-P, Sommet A, Bourrel R, Oustric S, Pathak A, Lapeyre-Mestre M, Montastruc J-L. Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study. Eur J Clin Pharmacol 2012;68:1533-40. [Ref.ID 93963]
9. Cita con resumen
Montastruc F, Montastruc G, Vigreux P, Bruneval P, Guilbeau-Frugier C, Cron C, Bagheri H, Delisle B, Lapeyre-Mestre M, Pathak A, Montastruc J-L. Valvular heart disease in a patient taking 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'). Br J Clin Pharmacol 2012;74:547-8. [Ref.ID 93709]
10. Cita con resumen
Braillon A, Bewley S, Herxheimer A, Mansfield P, Lexchin J, Menkes DB, Ziganshina LE, Montastruc J-L. Marketing versus evidence-based medicine. Lancet 2012;380:340. [Ref.ID 93515]
11. Cita con resumen
Pérez-Lloret S, Rey MV, Montastruc J-L. Syndrome des jambes sans repos: Les médicaments aussi !. BIP31.fr 2012;19:48. [Ref.ID 93270]
12. Cita con resumen
Pérez-Llobet S, Rey MV, Fabre N, Ory F, Spampinato U, Montastruc J-L, Rascol O. Do Parkinson's disease patients disclose their adverse events spontaneously?. Eur J Clin Pharmacol 2012;68:857-65. [Ref.ID 92830]
13.Enlace a cita original Cita con resumen
Montastruc F, Sommet A, Bondon-Guitton E, Durrieu G, Bui E, Bagheri H, Lapeyre-Mestre M, Schmitt L, Montastruc J-L. The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France. Eur J Clin Pharmacol 2012;68:767-75. [Ref.ID 92823]
14. Cita con resumen
Montastruc J-L. Médicaments déterminant HTA : du nouveau !. BIP31.fr 2012;19:19-20. [Ref.ID 92664]
15.Tiene citas relacionadas Cita con resumen
Montastruc J-L, Sommet A, Bagheri H, Lapeyre-Mestre M. Benefits and strenghts of the disproportionality analysis of identification of adverse drug reactions in a pharmacovigilance database. Br J Clin Pharmacol 2011;72:905-8. [Ref.ID 91873]
16. Cita con resumen
Rouve N, Bagheri H, Telmon N, Pathak A, Franchitto N, Schmitt L, Rougé D, Lapeyre-Mestre M, Montastruc J-L, The French Association of Regional PharmacoVigilance Centres. Prescribed drugs and violence: a case/noncase study in the French PharmacoVigilance Database. Eur J Clin Pharmacol 2011;67:1189-98. [Ref.ID 91779]
17.Tiene citas relacionadas Cita con resumen
Hillaire-Buys D, Faillie J-L, Montastruc J-L. Pioglitazone and bladder cancer. Lancet 2011;378:1543-4. [Ref.ID 91767]
18. Cita con resumen
Lacroix I, Berrebi A, Garipuy D, Schmitt L, Hammou Y, Chaumerliac C, Lapeyre-Mestre M, Montastruc J-L, Damase-Michel C. Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study. Eur J Clin Pharmacol 2011;67:1053-9. [Ref.ID 91555]
19.
Senard-Ojero A, Durrieu G, Depiesse F, Schmitt L, Riviere D, Montastruc J-L. Consommation de substances interdites chez le sportif: étude à l'Antenne Médicale de Prévention du Dopage de Midi-Pyrénées (AMPD-MP). Therapie 2010;65:459-63. [Ref.ID 89879]
20. Cita con resumen
Olivier P, Montastruc J-L. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France. Pharmacoepidemiol Drug Saf 2006;15:808-12. [Ref.ID 88737]
Seleccionar todas
 
 1 a 20 de 97 siguiente >>